These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 14729742)

  • 21. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A; McKinney CE; Rinaldi M; Zarlenga DS; Bannerman DD
    Vet Microbiol; 2007 Nov; 125(1-2):80-90. PubMed ID: 17560054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammalian defensins: structures and mechanism of antibiotic activity.
    Sahl HG; Pag U; Bonness S; Wagner S; Antcheva N; Tossi A
    J Leukoc Biol; 2005 Apr; 77(4):466-75. PubMed ID: 15582982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sequence requirements and an optimization strategy for short antimicrobial peptides.
    Hilpert K; Elliott MR; Volkmer-Engert R; Henklein P; Donini O; Zhou Q; Winkler DF; Hancock RE
    Chem Biol; 2006 Oct; 13(10):1101-7. PubMed ID: 17052614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
    Eley A; Ibrahim M; Kurdi SE; Conlon JM
    Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activities of four frog skin-derived antimicrobial peptides (temporin-1DRa, temporin-1Va and the melittin-related peptides AR-23 and RV-23) against anaerobic bacteria.
    Urbán E; Nagy E; Pál T; Sonnevend A; Conlon JM
    Int J Antimicrob Agents; 2007 Mar; 29(3):317-21. PubMed ID: 17196372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibacterial spectrum of antibacterial peptides from Musca domestica larvae and synergic interaction between the peptides and antibiotics].
    Gong X; Le GW; Li YF
    Wei Sheng Wu Xue Bao; 2005 Aug; 45(4):516-20. PubMed ID: 16245861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mode of action of membrane active antimicrobial peptides.
    Shai Y
    Biopolymers; 2002; 66(4):236-48. PubMed ID: 12491537
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Licci A; Nadolski P; Riva A; Lukasiak J; Scalise G
    Int J Antimicrob Agents; 2005 Sep; 26(3):235-40. PubMed ID: 16122911
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure and mode of action of the antimicrobial peptide arenicin.
    Andrä J; Jakovkin I; Grötzinger J; Hecht O; Krasnosdembskaya AD; Goldmann T; Gutsmann T; Leippe M
    Biochem J; 2008 Feb; 410(1):113-22. PubMed ID: 17935487
    [TBL] [Abstract][Full Text] [Related]  

  • 30. De novo design of selective antibiotic peptides by incorporation of unnatural amino acids.
    Hicks RP; Bhonsle JB; Venugopal D; Koser BW; Magill AJ
    J Med Chem; 2007 Jun; 50(13):3026-36. PubMed ID: 17547385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of dimerization of the cell-penetrating peptide Tat analog on antimicrobial activity and mechanism of bactericidal action.
    Zhu WL; Shin SY
    J Pept Sci; 2009 May; 15(5):345-52. PubMed ID: 19206074
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthetic antimicrobial peptidomimetics with therapeutic potential.
    Haug BE; Stensen W; Kalaaji M; Rekdal Ø; Svendsen JS
    J Med Chem; 2008 Jul; 51(14):4306-14. PubMed ID: 18570363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro antibacterial activity of the peptide PsVP-10 against antimicrobial-resistant Enterococcus faecalis isolated from clinical samples.
    Padilla C; Lobos O; Brevis P; Abaca P; Hubert E
    J Antimicrob Chemother; 2004 Feb; 53(2):390-2. PubMed ID: 14729763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bactericidal and membrane disruption activities of the eosinophil cationic protein are largely retained in an N-terminal fragment.
    Torrent M; de la Torre BG; Nogués VM; Andreu D; Boix E
    Biochem J; 2009 Jul; 421(3):425-34. PubMed ID: 19450231
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of amino acids as mediators for the antibacterial activity of iodine-lithium-alpha-dextrin in vitro and in vivo.
    Davtyan TK; Hakobyan IS; Muradyan RE; Hovhannisyan HG; Gabrielyan ES
    J Antimicrob Chemother; 2007 Jun; 59(6):1114-22. PubMed ID: 17439975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial properties of traditionally used Indian medicinal plants.
    Aqil F; Ahmad I
    Methods Find Exp Clin Pharmacol; 2007 Mar; 29(2):79-92. PubMed ID: 17440624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antimicrobial activity of SMAP-29 against the Bacteroides fragilis group and clostridia.
    Arzese A; Skerlavaj B; Tomasinsig L; Gennaro R; Zanetti M
    J Antimicrob Chemother; 2003 Sep; 52(3):375-81. PubMed ID: 12917245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial peptides: new candidates in the fight against bacterial infections.
    Toke O
    Biopolymers; 2005; 80(6):717-35. PubMed ID: 15880793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antimicrobial activity of Bac7 fragments against drug-resistant clinical isolates.
    Benincasa M; Scocchi M; Podda E; Skerlavaj B; Dolzani L; Gennaro R
    Peptides; 2004 Dec; 25(12):2055-61. PubMed ID: 15572192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
    Zerbini E; Andreu D; Tonarelli G; Sequeira MD
    Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.